Ritter Daniher Financial Advisory’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Hold
1,257
0.02% 180
2026
Q1
$151K Sell
1,257
-49
-4% -$5.66K 0.03% 181
2025
Q4
$137K Buy
1,306
+143
+12% +$13.4K 0.02% 193
2025
Q3
$97.6K Hold
1,163
0.02% 192
2025
Q2
$92.1K Buy
1,163
+686
+144% +$54.5K 0.02% 131
2025
Q1
$42.8K Hold
477
0.01% 176
2024
Q4
$47.5K Hold
477
0.01% 165
2024
Q3
$54.2K Hold
477
0.02% 150
2024
Q2
$59.1K Sell
477
-15
-3% -$1.93K 0.02% 137
2024
Q1
$64.9K Hold
492
0.02% 131
2023
Q4
$53.6K Hold
492
0.02% 144
2023
Q3
$50.7K Hold
492
0.02% 141
2023
Q2
$56.8K Hold
492
0.02% 128
2023
Q1
$52.3K Hold
492
0.02% 134
2022
Q4
$54.6K Hold
492
0.03% 138
2022
Q3
$42K Sell
492
-25
-5% -$2.23K 0.03% 126
2022
Q2
$47K Hold
517
0.03% 114
2022
Q1
$42K Hold
517
0.03% 121
2021
Q4
$40K Buy
517
+131
+34% +$10.4K 0.03% 117
2021
Q3
$29K Hold
386
0.02% 130
2021
Q2
$30K Sell
386
-19
-5% -$1.41K 0.02% 121
2021
Q1
$30K Hold
405
0.02% 113
2020
Q4
$32K Buy
+405
New +$31K 0.03% 108

Other funds holding MRK

Ritter Daniher Financial Advisory's MRK Position: Q2 2026 in Review

Ritter Daniher Financial Advisory held its Merck (MRK) position steady in Q2 2026 at 1,257 shares worth $162K. The position accounts for 0.02% of the portfolio, ranked #180.

Ritter Daniher Financial Advisory first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ritter Daniher Financial Advisory held 1,257 shares of Merck worth $162K as of Q2 2026.
  • Ritter Daniher Financial Advisory left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.02% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #180 holding.
  • Ritter Daniher Financial Advisory first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.